104 related articles for article (PubMed ID: 3155580)
1. Further phenotypic characterization of T cells after human allogeneic bone marrow transplantation.
Elfenbein GJ; Ashkenazi YJ; Barth KC
Transplantation; 1985 Jan; 39(1):97-102. PubMed ID: 3155580
[No Abstract] [Full Text] [Related]
2. Monitoring of T-lymphocyte regeneration following allogeneic bone marrow transplantation using monoclonal antibodies.
Gratama JW; Bolhuis RL
Neth J Med; 1985; 28(3):128-33. PubMed ID: 3157071
[No Abstract] [Full Text] [Related]
3. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric analysis of T lymphocyte subsets after human bone marrow transplantation using monoclonal antibodies and dual immunofluorescence].
Matsue K; Yasue S; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Matsuda T; Harada M
Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):659-64. PubMed ID: 2694718
[TBL] [Abstract][Full Text] [Related]
5. T-lymphocyte subpopulations identified by monoclonal antibodies after human bone-marrow transplantation.
Tubiana N; Maraninchi D; Mawas C; Lecaer F; Sainty D; Sebahoun G; Olive D; Gastaut JA; Carcassonne Y
Pathol Biol (Paris); 1985 Mar; 33(3):173-8. PubMed ID: 3892443
[TBL] [Abstract][Full Text] [Related]
6. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
7. Regeneration of lymphocyte subpopulations after bone marrow transplantation: a study with monoclonal antibodies of the BL-series.
Pönisch W; Leiblein S; Friedrich T; Schwenke H; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):527-30. PubMed ID: 2480302
[No Abstract] [Full Text] [Related]
8. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients.
Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105
[No Abstract] [Full Text] [Related]
10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
[TBL] [Abstract][Full Text] [Related]
12. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
[No Abstract] [Full Text] [Related]
13. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
14. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
Irlé C; Kaestli M; Chapuis B; Jeannet M
Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
[TBL] [Abstract][Full Text] [Related]
16. OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.
Prentice HG
J Clin Immunol; 1982 Jul; 2(3 Suppl):148S-153S. PubMed ID: 6290527
[TBL] [Abstract][Full Text] [Related]
17. Human regulatory T-cell subsets.
Young M; Geha RS
Annu Rev Med; 1986; 37():165-72. PubMed ID: 2939789
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
de Vries E; van Tol MJ; van den Bergh RL; Waaijer JL; ten Dam MM; Hermans J; Vossen JM
Bone Marrow Transplant; 2000 Feb; 25(3):267-75. PubMed ID: 10673698
[TBL] [Abstract][Full Text] [Related]
19. Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens.
Myburgh JA; Smit JA; Stark JH; Browde S
J Immunol; 1984 Feb; 132(2):1019-25. PubMed ID: 6228586
[TBL] [Abstract][Full Text] [Related]
20. T-cell phenotypic profile and colony formation during recovery from cytotoxic therapy-induced marrow aplasia.
Ashkenazi YJ; Barth KC; Elfenbein GJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6513-8. PubMed ID: 3933827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
